These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16586080)

  • 1. Mapping of treatment-induced apoptosis in normal structures: 99mTc-Hynic-rh-annexin V SPECT and CT image fusion.
    Kartachova MS; Valdés Olmos RA; Haas RL; Hoebers FJ; van den Brekel MW; van Zandwijk N; Herk Mv; Verheij M
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):893-9. PubMed ID: 16586080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response.
    Kartachova M; Haas RL; Olmos RA; Hoebers FJ; van Zandwijk N; Verheij M
    Radiother Oncol; 2004 Sep; 72(3):333-9. PubMed ID: 15450733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome.
    Kartachova MS; Valdés Olmos RA; Haas RL; Hoebers FJ; van Herk M; Verheij M
    Nucl Med Commun; 2008 Jan; 29(1):39-44. PubMed ID: 18049096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
    Belhocine T; Steinmetz N; Hustinx R; Bartsch P; Jerusalem G; Seidel L; Rigo P; Green A
    Clin Cancer Res; 2002 Sep; 8(9):2766-74. PubMed ID: 12231515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
    Gabriel M; Hausler F; Bale R; Moncayo R; Decristoforo C; Kovacs P; Virgolini I
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy.
    Hoebers FJ; Kartachova M; de Bois J; van den Brekel MW; van Tinteren H; van Herk M; Rasch CR; Valdés Olmos RA; Verheij M
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):509-18. PubMed ID: 17994297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.
    Vermeersch H; Mervillie K; Lahorte C; Loose D; Dierck RA; Steinmetz N; Cuvelier C; Slegers G; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1016-21. PubMed ID: 15014904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck.
    Loose D; Vermeersch H; De Vos F; Deron P; Slegers G; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):47-52. PubMed ID: 17906858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland.
    Kainz H; Bale R; Donnemiller E; Gabriel M; Kovacs P; Decristoforo C; Moncayo R
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1155-9. PubMed ID: 12811420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models].
    Lan XL; Zhang YX; He Y; Sun X; An R; Gao ZR; Cao GX
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.
    Ohtsuki K; Akashi K; Aoka Y; Blankenberg FG; Kopiwoda S; Tait JF; Strauss HW
    Eur J Nucl Med; 1999 Oct; 26(10):1251-8. PubMed ID: 10541822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of co-registered respiratory-gated( 99m)Tc-Technegas/MAA SPECT-CT images in the assessment of regional lung functional impairment in patients with lung cancer.
    Suga K; Kawakami Y; Zaki M; Yamashita T; Shimizu K; Matsunaga N
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1280-90. PubMed ID: 15197501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.
    van de Wiele C; Lahorte C; Vermeersch H; Loose D; Mervillie K; Steinmetz ND; Vanderheyden JL; Cuvelier CA; Slegers G; Dierck RA
    J Clin Oncol; 2003 Sep; 21(18):3483-7. PubMed ID: 12972524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
    Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
    Tait JF; Smith C; Blankenberg FG
    J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
    Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
    Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
    Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis.
    Tokita N; Hasegawa S; Maruyama K; Izumi T; Blankenberg FG; Tait JF; Strauss HW; Nishimura T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):232-8. PubMed ID: 12552341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients.
    Rottey S; Van den Bossche B; Slegers G; Van Belle S; van de Wiele C
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):127-32. PubMed ID: 19039304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.